Abstract
Graves’ hyperthyroid patients were treated daily for 10 days with 1 g sodium ipodate, a cholecystographic agent which exerts a blocking effect on the peripheral conversion of T4 to T3, or with 12 drops of saturated solution of potassium iodide (SSKI). Serum concentrations of free T4 (FT4) and free T3 (FT3) were measured before, during and 5 and 10 days after the administration of each drug. Sodium ipodate treatment induced a rapid decrement of serum FT4 concentrations which declined from 48.9 ± 6.6 pg/ml to 26.0 ± 2.7 pg/ml. In these patients serum FT3 concentrations declined from 12.4 ± 2.0 pg/ml to 2.5 ± 0.4 pg/ml. Ten days after sodium ipodate withdrawal, serum FT4 and FT3 concentrations returned to baseline values. In patients treated with SSKI serum FT4 concentrations declined from 51.1 ± 8.8 pg/ml to 11.3 ± 1.4 pg/ml and FT3 from 15.7 ± 2 pg/ml to 2.6 ± 0.3 pg/ml. Moreover, after therapy interruption serum free thyroid hormone concentrations returned to baseline values in these patients. Serum FT4 pattern during the study was not different between the two groups of subjects whereas serum FT3 concentrations were significantly lower in patients treated with sodium ipodate. These findings indicate that SSKI and sodium ipodate are effective in inducing a rapid decrement of serum free thyroid hormone concentrations. Therefore the employment of these drugs may be useful in the treatment of patients with thyroid storm and those undergoing thyroidectomy.
Similar content being viewed by others
References
Brown J., Solomon D.H., Beall G.N., Terasaki P.I., Chopra I.J., Van Herle A.J., Wu S.Y. Autoimmune thyroid diseases. Graves’ and Hashimoto’s. Ann. Intern. Med. 88: 379, 1978.
Wu S.Y., Chopra I.J., Solomon D.H., Bennett L.R. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (oragraphin), an agent for oral cholecystography. J. Clin. Endocrinol. Metab. 46: 691, 1978.
Wu S.Y., Chopra I.J., Solomon D.H., Jonhson D.E. The effect of repeated administration of ipodate (oragrafin) in hyperthyroidism. J. Clin. Endocrinol. Metab. 47: 1358, 1978.
Wu S.Y., Shyh T.P., Chopra I.J., Solomon D.H., Huang H. W., Chu P.C. Comparison of sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism. J. Clin. Endocrinol. Metab. 54: 630, 1982.
Emerson C.H., Anderson A.J., Howard W.J., Utiger R.D. Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J. Clin. Endocrinol. Metab. 40: 33, 1975.
Braverman L.E. Is there a place for long term stable iodine in the treatment of Graves’ disease? In: Hamburger J.I., Miller J.M. (Eds.), Controversies in Clinical Thyroidology. Springer-Verlag, New York, 1981, p. 164.
Roti E., Robuschi G., Manfredi A., d’Amato L., Gardini E., Salvi M., Montermini M., Barilli A.L., Gnudi A., Braverman L.E. Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves’ disease. Clin. Endocrinol. (Oxf.) 22: 489, 1985.
Robbins J., Johnson M.L. Theoretical considerations in the transport of the thyroid hormones in blood. In: Ekins R., Faglia G., Pennisi F., Pinchera A. (Eds.), Free Thyroid Hormones. Excerpta Medica, Amsterdam, 1979, p. 1.
Kramer C.Y. Extension of multiple range tests to group means with unequal number of replication. Biometrics 13: 307, 1956.
Hamburger J.I. Is there a place for long term stable iodine in the treatment of Graves’ disease? In: Hamburger J.I., Miller J.M. (Eds.), Controversies in Clinical Thyroidology. Springer Verlag, New York, 1981, p. 159.
Costa A. The use of X-ray contrast media in the treatment of hyperthyroidism. J. Endocrinol. Invest. 2: 461, 1979 (letter)
Wartofsky L., Ransil B.J., Ingbar S.H. Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J. Clin. Invest. 49: 78, 1970.
Chopra I.J., Solomon D.H., Chopra U., Wu S.Y., Fisher D.A., Nakamura Y. Pathways of metabolism of thyroid hormones. Recent. Prog. Horm. Res. 34: 521, 1978.
Kaplan M.M., Utiger R.D. Iodothyronine metabolism in rat liver homogenate. J. Clin. Invest. 67: 459, 1978.
Silva J.E., Dick T.E., Larsen P.R. The contribution of local tissue thyroxine monodeiodination to the nuclear 3, 5, 3′-triiodothyronine in pituitary, liver and kidney of euthyroid rats. Endocrinology 103: 1196, 1978.
Felicetta J.V., Green W.L., Nelp W.B. Inhibition of hepatic binding of thyroxine by cholecystography agents. J. Clin. Invest. 65: 1032, 1980.
Emanuele R., Robuschi G., Tagliaferri A., d’Amato L., Salvi M., Gnudi A., Manfredi A., Tecchio T., Roti E. Iodothyronine and thyrotropin concentrations after iodoamide administration for angiographic studies. La Ricerca 12: 589, 1982.
Kleinmann R.E., Sternthal E., Starobin O., Braverman L. E. Cardiac catheterization dye does not affect serum thyroid hormone concentrations or TSH secretion. Cathet. Cardiovasc. Diagn. 8: 261, 1982.
Grayson R.R. Factors which influence the radioactive iodine thyroidal uptake test. Am. J. Med. 28: 397, 1960.
Burgi H., Wimpfheimer C., Burger A., Zaunbauer W., Rösier H., Lemarchand-Beraud T. Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J. Clin. Endocrinol. Metab. 43: 1203, 1976.
Beng C.G., Wellby M.L., Symons R.G., Stuart S., Marshall J. The effect of ipodate on the serum iodothyronine pattern in normal subjects. Acta Endocrinol. (Kbh.) 93: 175, 1980.
Sharp B., Reed A.W., Tamagna E.I., Geffner D.L., Hershman J.M. Treatment of hyperthyroidism with sodium ipodate (oragraphin) in addition to propylthiouracil and propranolol. J. Clin. Endocrinol. Metab. 53: 622, 1981.
Wartofsky L. Low remission after therapy for Graves’ disease: possible relation of dietary iodine with antithyroid therapy results. JAMA 226: 1083, 1973.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robuschi, G., Manfredi, A., Salvi, M. et al. Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves’ disease. J Endocrinol Invest 9, 287–291 (1986). https://doi.org/10.1007/BF03346928
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346928